🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Joel Greenblatt’s HNGE Holdings & Trades

First Buy
Q2 2026
Duration Held
2 Quarters
Largest Add
Q3 2026
+12,524 Shares
Current Position
15,616 Shares
$1.52 M Value

Joel Greenblatt's HNGE Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 15,616 shares of Hinge Health, Inc. (HNGE) worth $1.52 M, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Joel Greenblatt has initiated a new position in HNGE, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2026, adding 12,524 shares.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's Hinge Health (HNGE) Holding Value Over Time

Track share changes against reported price movement

Quarterly Hinge Health (HNGE) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +12,524 Add 405.05% 15,616 $97.24
Q2 2026 +3,092 New Buy 3,092 $83.00

Joel Greenblatt's Hinge Health Investment FAQs

Joel Greenblatt first purchased Hinge Health, Inc. (HNGE) in Q2 2026, acquiring 3,092 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held Hinge Health, Inc. (HNGE) for 2 quarters since Q2 2026.

Joel Greenblatt's largest addition to Hinge Health, Inc. (HNGE) was in Q3 2026, adding 15,616 shares worth $1.52 M.

According to the latest 13F filing for Q3 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 15,616 shares of Hinge Health, Inc. (HNGE), valued at approximately $1.52 M.

As of the Q3 2026 filing, Hinge Health, Inc. (HNGE) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in Hinge Health, Inc. (HNGE) was 15,616 shares, as reported at the end of Q3 2026.